Krystal Biotech
Pittsburgh
About Krystal Biotech
Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that provide significant clinical benefit for patients suffering from rare debilitating disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $546.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2023)
- Ticker: nasdaq:KRYS
- Website: krystalbio.com
- Phone: +1 412-586-5830
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/krystal-biotech-536 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.